COLA Accredited | Medicare Approved | Ready for Validation | Relocatable or Retainable Space
Asking Price:

$150,000 – Without Equipment

$175,000 – With Equipment
(Additional ancillary services negotiable)

A newly equipped, high complexity COLA-accredited laboratory in Texas (Novitas MAC region) is available for acquisition.

The facility has been fully built out with all major instrumentation and consumables in place and is pending validation (scheduled but can be postponed if relocation is preferred).
This is a turnkey opportunity for a buyer seeking immediate entry into molecular, toxicology, or clinical testing with Medicare billing infrastructure already established.

Accreditation & Regulatory

-Accreditation: COLA
-MAC Region: Novitas
-Medicare: Approved with EFT already established and linked to a bank account
-Validation Status: Scheduled and ready; can be postponed or transferred with sale

Facility & Equipment

This laboratory is newly outfitted with all core instruments and materials required for molecular, chemistry, and toxicology testing.

Included Equipment (if purchased with assets):

-Bio-Rad PCR system
-Large Thermo Fisher PCR hood
-Clinical-grade refrigerator and freezer units
-Centrifuges (multiple units)
-Single-channel and multi-channel pipettes
-Complete PCR setup (thermocycler, vortexers, heat blocks)
-Benchtop equipment, consumables, and workstations

*All equipment is newly installed, unused, and easily relocatable. Equipment package can be included or excluded based on buyer preference.

Testing & Reference Contracts

Established reference and vendor contracts are already in place for:

-PCR Panels
-Pharmacogenomics (PGX)
-Toxicology
-Chemistry and Hematology

*These agreements enable seamless activation of testing services upon completion of validation and licensing under new ownership.

Operational Infrastructure

-Billing: Fully established billing company and NextGen billing software with immediate ability to bill Medicare
-Staffing & Management:
-Current management team available for continued support
-Medical Director willing to remain post-sale if desired

Highlights

-Brand-new, fully equipped high complexity laboratory in Texas
-COLA accreditation and Medicare EFT approval already in place
-Validation scheduled (can be postponed or transferred)
-Reference contracts for core molecular and chemistry testing
-Ready-to-bill infrastructure with NextGen billing software
-Flexible relocation or continued operation options

For confidential details and inquiries, contact:
Laboratory Nexus — derek@laboratorynexus.com